eIF2α Rabbit pAb (APR17550N) APR17550N
Specifications
| 50µl / 100µl / 200µl |
Product info:
The translation initiation factor EIF2 catalyzes the first regulated step of protein synthesis initiation, promoting the binding of the initiator tRNA to 40S ribosomal subunits. Binding occurs as a ternary complex of methionyl-tRNA, EIF2, and GTP. EIF2 is composed of 3 nonidentical subunits, the 36-kD EIF2-alpha subunit (EIF2S1), the 38-kD EIF2-beta subunit (EIF2S2; MIM 603908), and the 52-kD EIF2-gamma subunit (EIF2S3; MIM 300161). The rate of formation of the ternary complex is modulated by the phosphorylation state of EIF2-alpha (Ernst et al., 1987 [PubMed 2948954]).[supplied by OMIM, Feb 2010]
Alternative names:
EIF-2; EIF-2A; EIF-2alpha; EIF2; EIF2A; EIF2S1
Species reactivity:
Human, Mouse, Rat
Host:
Rabbit
Cellular localisation:
Cytoplasmic granule
Isotype:
IgG
Immunogen:
Recombinant fusion protein containing a sequence corresponding to amino acids 1-260 of human eIF2α (NP_004085.1).
Positive control:
LO2, Jurkat, MCF7, SW480, SKOV3, Mouse kidney, Mouse spleen
AA Sequence:
MPGLSCRFYQHKFPEVEDVVMVNVRSIAEMGAYVSLLEYNNIEGMILLSELSRRRIRSINKLIRIGRNECVVVIRVDKEKGYIDLSKRRVSPEEAIKCEDKFTKSKTVYSILRHVAEVLEYTKDEQLESLFQRTAWVFDDKYKRPGYGAYDAFKHAVSDPSILDSLDLNEDEREVLINNINRRLTPQAVKIRADIEVACYGYEGIDAVKEALRAGLNCSTENMPIKINLIAPPRYVMTTTTLERTEGLSVLSQAMAVIKE
Purification:
Affinity purification
Molecular weight:
Calculated MW: 36kDa Observed MW: 36kDa
Form:
Liquid
Applications:
WB (293T cells, Homo sapiens, Mus musculus, Rattus norvegicus)
Dilution:
WB 1:500 - 1:1000 IHC 1:50 - 1:200 IF 1:50 - 1:200
Storage buffer:
Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Storage:
Store at 4°C short term. For long-term storage, aliquot and store at -20°C or below. Stable for 12 months at -20°C. Avoid repeated freeze-thaw cycles.
More info:
Email: info@sobekbio.com
Orders:
Email: orders@sobekbio.com

GlycoSeLect Ltd specializes in the development and production of Recombinant Prokaryotic Lectins (RPLs).
Micronbrane Medical’s genomic innovations enrich our understanding of microorganisms to benefit human health and sustainability. The company's proprietary technologies include the patented Devin™ host depletion, mNGS-grade reagents with the PaRTI-Seq assay, plus rapid bioinformatic analysis software. The combined Micronbrane Medical solution enables comprehensive and cost-effective identification of a broad range of microorganisms, including bacteria, fungi, viruses, and parasites. The company has partnerships and collaborations with leading academic institutions, health systems, and laboratories worldwide.